Safety, tolerability and pharmacokinetics of SUVN-502 - A 5-HT 6 receptor antagonist, first in human phase-1 Single Ascending Dose (SAD) study

标题
Safety, tolerability and pharmacokinetics of SUVN-502 - A 5-HT 6 receptor antagonist, first in human phase-1 Single Ascending Dose (SAD) study
作者
关键词
-
出版物
Alzheimers & Dementia
Volume 5, Issue 4, Pages P250
出版商
Elsevier BV
发表日期
2009-06-25
DOI
10.1016/j.jalz.2009.04.260

向作者/读者发起求助以获取更多资源

Find Funding. Review Successful Grants.

Explore over 25,000 new funding opportunities and over 6,000,000 successful grants.

Explore

Find the ideal target journal for your manuscript

Explore over 38,000 international journals covering a vast array of academic fields.

Search